vs
Side-by-side financial comparison of D-Wave Quantum Inc. (QBTS) and Instil Bio, Inc. (TIL). Click either name above to swap in a different company.
D-Wave Quantum Inc. is the larger business by last-quarter revenue ($2.8M vs $2.2M, roughly 1.2× Instil Bio, Inc.). Instil Bio, Inc. runs the higher net margin — -365.3% vs -1538.0%, a 1172.7% gap on every dollar of revenue. On growth, D-Wave Quantum Inc. posted the faster year-over-year revenue change (19.2% vs -19.2%).
D-Wave Quantum Inc. is a quantum computing company with locations in Palo Alto, California and Burnaby, British Columbia. D-Wave claims to be the world's first company to sell computers that exploit quantum effects in their operation. D-Wave's early customers include Lockheed Martin, the University of Southern California, Google/NASA, and Los Alamos National Laboratory.
Instil Bio Inc. is a clinical-stage biotechnology company focused on developing innovative tumor-infiltrating lymphocyte (TIL) therapies for patients with difficult-to-treat advanced solid tumors. It operates in the immuno-oncology segment, serving patient populations that show limited response to existing standard cancer treatment options.
QBTS vs TIL — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $2.8M | $2.2M |
| Net Profit | $-42.3M | $-8.2M |
| Gross Margin | 64.8% | — |
| Operating Margin | -1266.0% | -426.3% |
| Net Margin | -1538.0% | -365.3% |
| Revenue YoY | 19.2% | -19.2% |
| Net Profit YoY | 50.8% | 31.1% |
| EPS (diluted) | $-0.13 | $-1.13 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $2.8M | $2.2M | ||
| Q3 25 | $3.7M | $2.2M | ||
| Q2 25 | $3.1M | $2.2M | ||
| Q1 25 | $15.0M | $2.2M | ||
| Q4 24 | $2.3M | $2.8M | ||
| Q3 24 | — | $1.5M | ||
| Q2 24 | $2.2M | $0 | ||
| Q1 24 | $2.5M | $0 |
| Q4 25 | $-42.3M | $-8.2M | ||
| Q3 25 | $-140.0M | $-13.6M | ||
| Q2 25 | $-167.3M | $-21.4M | ||
| Q1 25 | $-5.4M | $-28.2M | ||
| Q4 24 | $-86.1M | $-11.9M | ||
| Q3 24 | — | $-23.0M | ||
| Q2 24 | $-17.8M | $-14.9M | ||
| Q1 24 | $-17.3M | $-24.3M |
| Q4 25 | 64.8% | — | ||
| Q3 25 | 71.4% | — | ||
| Q2 25 | 63.8% | — | ||
| Q1 25 | 92.5% | — | ||
| Q4 24 | 63.8% | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 63.6% | — | ||
| Q1 24 | 67.3% | — |
| Q4 25 | -1266.0% | -426.3% | ||
| Q3 25 | -741.8% | -670.0% | ||
| Q2 25 | -856.3% | -1045.5% | ||
| Q1 25 | -75.3% | -1363.2% | ||
| Q4 24 | -876.2% | -426.1% | ||
| Q3 24 | — | -1582.8% | ||
| Q2 24 | -863.0% | — | ||
| Q1 24 | -710.6% | — |
| Q4 25 | -1538.0% | -365.3% | ||
| Q3 25 | -3743.9% | -606.0% | ||
| Q2 25 | -5406.4% | -954.2% | ||
| Q1 25 | -36.1% | -1257.8% | ||
| Q4 24 | -3727.9% | -428.8% | ||
| Q3 24 | — | -1541.9% | ||
| Q2 24 | -814.4% | — | ||
| Q1 24 | -702.3% | — |
| Q4 25 | $-0.13 | $-1.13 | ||
| Q3 25 | $-0.41 | $-2.01 | ||
| Q2 25 | $-0.55 | $-3.24 | ||
| Q1 25 | $-0.02 | $-4.32 | ||
| Q4 24 | $-0.43 | $-1.82 | ||
| Q3 24 | — | $-3.54 | ||
| Q2 24 | $-0.10 | $-2.29 | ||
| Q1 24 | $-0.11 | $-3.74 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $884.5M | $6.6M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $852.2M | $113.9M |
| Total Assets | $915.8M | $203.5M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $884.5M | $6.6M | ||
| Q3 25 | $836.2M | $5.8M | ||
| Q2 25 | $819.3M | $7.7M | ||
| Q1 25 | $304.3M | $15.4M | ||
| Q4 24 | $178.0M | $8.8M | ||
| Q3 24 | — | $6.7M | ||
| Q2 24 | — | $6.8M | ||
| Q1 24 | — | $5.5M |
| Q4 25 | $852.2M | $113.9M | ||
| Q3 25 | $670.6M | $120.4M | ||
| Q2 25 | $694.3M | $131.7M | ||
| Q1 25 | $207.4M | $144.9M | ||
| Q4 24 | $62.6M | $169.4M | ||
| Q3 24 | — | $176.3M | ||
| Q2 24 | $-21.5M | $195.0M | ||
| Q1 24 | $-37.0M | $205.8M |
| Q4 25 | $915.8M | $203.5M | ||
| Q3 25 | $865.8M | $211.8M | ||
| Q2 25 | $843.6M | $231.0M | ||
| Q1 25 | $325.6M | $237.4M | ||
| Q4 24 | $199.9M | $263.6M | ||
| Q3 24 | — | $272.6M | ||
| Q2 24 | $61.8M | $294.3M | ||
| Q1 24 | $48.6M | $306.3M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-18.4M | $-7.1M |
| Free Cash FlowOCF − Capex | $-20.0M | — |
| FCF MarginFCF / Revenue | -727.9% | — |
| Capex IntensityCapex / Revenue | 60.3% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-75.8M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-18.4M | $-7.1M | ||
| Q3 25 | $-19.0M | $-10.6M | ||
| Q2 25 | $-15.3M | $-14.8M | ||
| Q1 25 | $-19.3M | $-4.2M | ||
| Q4 24 | $2.0M | $-10.6M | ||
| Q3 24 | — | $-20.1M | ||
| Q2 24 | $-14.5M | $-10.6M | ||
| Q1 24 | $-12.1M | $-14.4M |
| Q4 25 | $-20.0M | — | ||
| Q3 25 | $-20.1M | — | ||
| Q2 25 | $-16.0M | — | ||
| Q1 25 | $-19.7M | — | ||
| Q4 24 | $1.1M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | $-15.0M | — | ||
| Q1 24 | $-12.4M | — |
| Q4 25 | -727.9% | — | ||
| Q3 25 | -536.5% | — | ||
| Q2 25 | -518.1% | — | ||
| Q1 25 | -131.4% | — | ||
| Q4 24 | 46.2% | — | ||
| Q3 24 | — | — | ||
| Q2 24 | -687.7% | — | ||
| Q1 24 | -504.0% | — |
| Q4 25 | 60.3% | — | ||
| Q3 25 | 27.2% | — | ||
| Q2 25 | 24.2% | — | ||
| Q1 25 | 2.9% | — | ||
| Q4 24 | 41.1% | 0.0% | ||
| Q3 24 | — | 0.0% | ||
| Q2 24 | 25.0% | — | ||
| Q1 24 | 12.4% | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
QBTS
| Transferred Over Time | $2.4M | 89% |
| Other | $306.0K | 11% |
TIL
Segment breakdown not available.
